IART
Integra LifeSciences Holdings Corporation$10.70+0.01 (+0.05%)Prev Close$10.69·MCap$823.8M·P/E—·Vol620.0K·Yield—
▲
Buys (12M)
1
$102.2K
▼
Sells (12M)
7
$212.6K
◆
Net Activity
Net Seller
$110.5K
●
Active Insiders
7
last 12 mo
Over the past 12 months, insider activity at Integra LifeSciences Holdings Corporation (IART) has been dominated by selling, with 1 insider purchase totaling $102.2K and 7 insider sales totaling $212.6K. The most recent insider transaction was by Poul Mojdeh (President & CEO), who sold $18.3K worth of shares on Jan 6, 2026. Integra LifeSciences Holdings Corporation operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $823.8M.
IART Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Poul Mojdeh | President & CEO | Sell | 1,390 | $13.13 | $18.3K | 0 |
| Nov 5, 2025 | GRAVES JEFFREY A | Director | Buy | 9,000 | $11.35 | $102.2K | 0 |
| Oct 12, 2025 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Sell | 3,281 | $13.34 | $43.8K | 0 |
| Sep 1, 2025 | Veillon-Berteloot Chantal | EVP & CHRO | Sell | 3,551 | $15.13 | $53.7K | 0 |
| Jul 3, 2025 | Knight Lea Daniels | EVP & Chief Financial Officer | Sell | 2,561 | $13.49 | $34.5K | 0 |
| Jul 3, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 3,345 | $13.49 | $45.1K | 0 |
| Jul 1, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 937 | $13.25 | $12.4K | 0 |
| May 9, 2025 | BRADLEY KEITH | Director | Sell | 392 | $12.25 | $4.8K | 0 |
| Mar 11, 2025 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 1,379 | $23.95 | $33.0K | 0 |
| Mar 11, 2025 | Knight Lea Daniels | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,655 | $23.95 | $39.6K | 0 |
| Mar 11, 2025 | McBreen Michael J. | EVP & President, CSS | Sell | 2,033 | $23.95 | $48.7K | 0 |
| Mar 11, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 443 | $23.95 | $10.6K | 0 |
| Mar 11, 2025 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Sell | 2,718 | $23.95 | $65.1K | 0 |
| Mar 11, 2025 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Sell | 647 | $23.95 | $15.5K | 0 |
| Mar 11, 2025 | Veillon-Berteloot Chantal | EVP & CHRO | Sell | 524 | $23.95 | $12.5K | 0 |
| Mar 10, 2025 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 592 | $22.61 | $13.4K | 0 |
| Mar 10, 2025 | McBreen Michael J. | EVP & President, CSS | Sell | 2,285 | $22.61 | $51.7K | 0 |
| Mar 10, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 277 | $22.61 | $6.3K | 0 |
| Mar 10, 2025 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Sell | 773 | $22.61 | $17.5K | 0 |
| Mar 10, 2025 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Sell | 324 | $22.61 | $7.3K | 0 |
| Dec 4, 2024 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Sell | 4,070 | $24.60 | $100.1K | 59,511 |
| Dec 3, 2024 | McBreen Michael J. | EVP & President, CSS | Sell | 1,700 | $24.16 | $41.1K | 56,182 |
| Aug 20, 2024 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 1,191 | $21.58 | $25.7K | 36,088 |
| May 24, 2024 | ESSIG STUART | Exec. Chairman of the Board | Buy | 52,641 | $28.49 | $1.50M | 487,922 |
| May 22, 2024 | HILL BARBARA B | Director | Buy | 36,350 | $27.40 | $995.8K | 36,350 |
| Mar 8, 2024 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 8,348 | $36.59 | $305.5K | 49,893 |
| Aug 10, 2023 | Mosebrook Jeffrey | SVP, Fin & PAO | Sell | 1,177 | $44.46 | $52.3K | 23,458 |
| Jun 5, 2023 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Buy | 2,640 | $37.89 | $100.0K | 48,597 |
| Jun 2, 2023 | De Witte Jan | President & CEO | Buy | 7,792 | $38.50 | $300.0K | 12,798+156% |
| Mar 8, 2023 | McBreen Michael J. | EVP & President, CSS | Sell | 1,843 | $54.29 | $100.1K | 28,796 |
| Mar 3, 2023 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 1,566 | $55.21 | $86.5K | 45,920 |
| Feb 28, 2023 | Evoli Lisa | EVP & CHRO | Sell | 3,767 | $57.00 | $214.7K | 18,605 |
| Dec 8, 2022 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 279 | $56.22 | $15.7K | 8,552 |
| Aug 11, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 1,165 | $55.81 | $65.0K | 17,997 |
| Aug 8, 2022 | Murphy Raymond G. | Director | Sell | 8,000 | $55.78 | $446.3K | 40,825 |
| Aug 3, 2022 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 437 | $56.78 | $24.8K | 8,831 |
| Jun 16, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 900 | $55.93 | $50.3K | 19,911 |
| May 25, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 250 | $59.85 | $15.0K | 20,811 |
| Apr 6, 2022 | Coleman Glenn | Executive Vice President & COO | Sell | 6,268 | $66.04 | $413.9K | 41,288 |
| Mar 25, 2022 | Tru St Partnership, L.P. | 10% Owner | Sell | 300,000 | $64.86 | $19.46M | 8,740,930 |
| Mar 1, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 1,254 | $67.03 | $84.1K | 14,058 |
| Nov 19, 2021 | Tru St Partnership, L.P. | 10% Owner | Sell | 75,000 | $68.59 | $5.14M | 8,815,930 |
| Nov 12, 2021 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 700 | $70.88 | $49.6K | 6,008 |
| Nov 8, 2021 | McBreen Michael J. | EVP & President, CSS | Sell | 3,450 | $71.59 | $247.0K | 9,737-26% |
| Nov 3, 2021 | Coleman Glenn | Executive Vice President & COO | Sell | 4,275 | $74.00 | $316.4K | 27,781 |
| Oct 27, 2021 | Tru St Partnership, L.P. | 10% Owner | Sell | 200,000 | $69.81 | $13.96M | 8,890,930 |
| Sep 7, 2021 | Arduini Peter J | President & CEO | Sell | 118,434 | $75.88 | $8.99M | 216,713-35% |
| Aug 10, 2021 | McBreen Michael J. | EVP & President, CSS | Sell | 4,000 | $71.22 | $284.9K | 13,187 |
| Jun 7, 2021 | Murphy Raymond G. | Director | Sell | 1,253 | $67.22 | $84.2K | 45,369 |
| May 11, 2021 | Evoli Lisa | Executive Vice President &CHRO | Sell | 5,335 | $75.00 | $400.1K | 7,825-41% |
Showing 1–50 of 60
1 / 2
IART Insider Buying Activity
The following table shows recent insider purchases of Integra LifeSciences Holdings Corporation (IART) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025 | GRAVES JEFFREY A | Director | Buy | 9,000 | $11.35 | $102.2K | 0 |
| May 24, 2024 | ESSIG STUART | Exec. Chairman of the Board | Buy | 52,641 | $28.49 | $1.50M | 487,922 |
| May 22, 2024 | HILL BARBARA B | Director | Buy | 36,350 | $27.40 | $995.8K | 36,350 |
| Jun 5, 2023 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Buy | 2,640 | $37.89 | $100.0K | 48,597 |
| Jun 2, 2023 | De Witte Jan | President & CEO | Buy | 7,792 | $38.50 | $300.0K | 12,798+156% |
IART Insider Selling Activity
The following table shows recent insider sales of Integra LifeSciences Holdings Corporation (IART) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Poul Mojdeh | President & CEO | Sell | 1,390 | $13.13 | $18.3K | 0 |
| Oct 12, 2025 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Sell | 3,281 | $13.34 | $43.8K | 0 |
| Sep 1, 2025 | Veillon-Berteloot Chantal | EVP & CHRO | Sell | 3,551 | $15.13 | $53.7K | 0 |
| Jul 3, 2025 | Knight Lea Daniels | EVP & Chief Financial Officer | Sell | 2,561 | $13.49 | $34.5K | 0 |
| Jul 3, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 3,345 | $13.49 | $45.1K | 0 |
| Jul 1, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 937 | $13.25 | $12.4K | 0 |
| May 9, 2025 | BRADLEY KEITH | Director | Sell | 392 | $12.25 | $4.8K | 0 |
| Mar 11, 2025 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 1,379 | $23.95 | $33.0K | 0 |
| Mar 11, 2025 | Knight Lea Daniels | EVP & CHIEF FINANCIAL OFFICER | Sell | 1,655 | $23.95 | $39.6K | 0 |
| Mar 11, 2025 | McBreen Michael J. | EVP & President, CSS | Sell | 2,033 | $23.95 | $48.7K | 0 |
| Mar 11, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 443 | $23.95 | $10.6K | 0 |
| Mar 11, 2025 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Sell | 2,718 | $23.95 | $65.1K | 0 |
| Mar 11, 2025 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Sell | 647 | $23.95 | $15.5K | 0 |
| Mar 11, 2025 | Veillon-Berteloot Chantal | EVP & CHRO | Sell | 524 | $23.95 | $12.5K | 0 |
| Mar 10, 2025 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 592 | $22.61 | $13.4K | 0 |
| Mar 10, 2025 | McBreen Michael J. | EVP & President, CSS | Sell | 2,285 | $22.61 | $51.7K | 0 |
| Mar 10, 2025 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 277 | $22.61 | $6.3K | 0 |
| Mar 10, 2025 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Sell | 773 | $22.61 | $17.5K | 0 |
| Mar 10, 2025 | Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL | Sell | 324 | $22.61 | $7.3K | 0 |
| Dec 4, 2024 | Schwartz Eric | EVP, Chief Legal Officer & Sec | Sell | 4,070 | $24.60 | $100.1K | 59,511 |
| Dec 3, 2024 | McBreen Michael J. | EVP & President, CSS | Sell | 1,700 | $24.16 | $41.1K | 56,182 |
| Aug 20, 2024 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 1,191 | $21.58 | $25.7K | 36,088 |
| Mar 8, 2024 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 8,348 | $36.59 | $305.5K | 49,893 |
| Aug 10, 2023 | Mosebrook Jeffrey | SVP, Fin & PAO | Sell | 1,177 | $44.46 | $52.3K | 23,458 |
| Mar 8, 2023 | McBreen Michael J. | EVP & President, CSS | Sell | 1,843 | $54.29 | $100.1K | 28,796 |
| Mar 3, 2023 | DAVIS ROBERT T. JR. | EVP & President, TT | Sell | 1,566 | $55.21 | $86.5K | 45,920 |
| Feb 28, 2023 | Evoli Lisa | EVP & CHRO | Sell | 3,767 | $57.00 | $214.7K | 18,605 |
| Dec 8, 2022 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 279 | $56.22 | $15.7K | 8,552 |
| Aug 11, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 1,165 | $55.81 | $65.0K | 17,997 |
| Aug 8, 2022 | Murphy Raymond G. | Director | Sell | 8,000 | $55.78 | $446.3K | 40,825 |
| Aug 3, 2022 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 437 | $56.78 | $24.8K | 8,831 |
| Jun 16, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 900 | $55.93 | $50.3K | 19,911 |
| May 25, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 250 | $59.85 | $15.0K | 20,811 |
| Apr 6, 2022 | Coleman Glenn | Executive Vice President & COO | Sell | 6,268 | $66.04 | $413.9K | 41,288 |
| Mar 25, 2022 | Tru St Partnership, L.P. | 10% Owner | Sell | 300,000 | $64.86 | $19.46M | 8,740,930 |
| Mar 1, 2022 | Evoli Lisa | Executive Vice President &CHRO | Sell | 1,254 | $67.03 | $84.1K | 14,058 |
| Nov 19, 2021 | Tru St Partnership, L.P. | 10% Owner | Sell | 75,000 | $68.59 | $5.14M | 8,815,930 |
| Nov 12, 2021 | Mosebrook Jeffrey | SVP, Fin & Princ Acct Officer | Sell | 700 | $70.88 | $49.6K | 6,008 |
| Nov 8, 2021 | McBreen Michael J. | EVP & President, CSS | Sell | 3,450 | $71.59 | $247.0K | 9,737-26% |
| Nov 3, 2021 | Coleman Glenn | Executive Vice President & COO | Sell | 4,275 | $74.00 | $316.4K | 27,781 |
| Oct 27, 2021 | Tru St Partnership, L.P. | 10% Owner | Sell | 200,000 | $69.81 | $13.96M | 8,890,930 |
| Sep 7, 2021 | Arduini Peter J | President & CEO | Sell | 118,434 | $75.88 | $8.99M | 216,713-35% |
| Aug 10, 2021 | McBreen Michael J. | EVP & President, CSS | Sell | 4,000 | $71.22 | $284.9K | 13,187 |
| Jun 7, 2021 | Murphy Raymond G. | Director | Sell | 1,253 | $67.22 | $84.2K | 45,369 |
| May 11, 2021 | Evoli Lisa | Executive Vice President &CHRO | Sell | 5,335 | $75.00 | $400.1K | 7,825-41% |
IART Insiders
Similar Stocks to IART
ABT
Abbott Laboratories
$93.53+0.80%
$166.85B
SYK
Stryker Corporation
$321.11-2.38%
$129.58B
BSX
Boston Scientific Corporation
$58.34-2.68%
$90.64B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$287.57+0.00%
$47.35B
EW
Edwards Lifesciences Corporation
$81.85-1.93%
$47.30B
DXCM
DexCom, Inc.
$59.34-3.35%
$24.16B
ZBH
Zimmer Biomet Holdings, Inc.
$82.88-10.49%
$18.14B
ALGN
Align Technology, Inc.
$176.49-4.45%
$13.98B